09/06/2009 05:12 am ET Updated May 25, 2011

White House Stands By Behind-The-Scenes Deal With Drugmakers Under Industry Pressure

Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion.

Read more on New York Times